V Starnt 50mg Injection
Marketer
BDR Pharmaceuticals Internationals Pvt
Salt Composition
Fulvestrant (50mg/ml)
Overview V Starnt 50mg Injection
Estrogen-blocking medication, V Starnt 50mg Injection, is indicated for postmenopausal women with breast cancer. Its mechanism involves regulating estrogen levels to inhibit cancer cell proliferation. Administered intramuscularly under medical supervision, the dosage and frequency are individualized based on the patient's needs and determined by their physician to optimize symptom management. Treatment duration adheres to the prescribed regimen. Commonly reported adverse effects include injection site reactions, headache, nausea, vomiting, and allergic responses; patients experiencing bothersome or severe side effects should consult their doctor, as mitigating strategies may be available. Prior to initiating therapy, patients must disclose any history of kidney or liver disease, bleeding disorders, anticoagulant use, and all other concurrent medications to their physician, as drug interactions may impact efficacy or alter the drug's action. Pregnant or breastfeeding women, or those planning pregnancy, should inform their doctor before commencing treatment.
Uses of V Starnt 50mg Injection
Malignancy of the mammary gland
Major Benefits of V Starnt 50mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of V Starnt 50mg Injection:
- Headache
- Vomiting
- Weakness
- Allergic reaction
- Nausea
- Injection site reaction
- Urinary tract infection
- Diarrhea
How to use V Starnt 50mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How V Starnt 50mg Injection works:
V Starnt 50mg Injection inhibits estrogen's effects on breast cancer cells, potentially reducing or halting the proliferation of estrogen-dependent breast tumors.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol alongside V Starnt 50mg Injection requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering V Starnt 50mg Injection during pregnancy poses a confirmed risk to the fetus. Therefore, its use is contraindicated. Nevertheless, in exceptional, life-threatening circumstances, a physician might deem its use justifiable if the potential benefits outweigh the known hazards. Always seek medical advice before use.
Breast feedingUNSAFE
Administering V Starnt 50mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingSAFE
V Starnt 50mg Injection typically does not impair driving ability.
KidneyCAUTION
Exercise caution when administering V Starnt 50mg Injection to individuals with severe kidney impairment; dosage modification may be necessary. Consult a physician for guidance. Data regarding V Starnt 50mg Injection use in such patients is limited. Dosage alteration is not advised for those with mild to moderate kidney disease.
LiverCAUTION
Individuals with hepatic impairment should use V Starnt 50mg Injection cautiously. Dosage modification of V Starnt 50mg Injection might be necessary. Physician consultation is recommended.
What if you forget to take V Starnt 50mg Injection :
Omit a V Starnt 50mg Injection dose? Seek your physician's advice.
Facts to Know About V Starnt 50mg Injection
| Label | Value |
|---|---|
| Type of Compound | Estrogen-based medications |
| Potential for Dependence | None. |
| Type of Medication | Cancer-fighting drugs |
| Mechanism of Action | Estrogen receptor blocker |
3,018 People bought this recently